Business Context and Reporting Period
This Form 8-K Current Report was filed by Spherix Incorporated (not Dominari Holdings Inc.) on January 19, 2011. The report details the entry into a material definitive agreement involving a registered direct offering of equity securities.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.77 million.
- Net Proceeds: Expected to be approximately $2.6 million after deducting fees and expenses.
- Securities Issued: 4,269,000 shares of common stock and warrants to purchase up to 2,134,500 additional shares.
- Offering Price: $0.65 per unit (one share plus a warrant for 0.5 shares).
- Warrant Terms: Exercise price of $0.80 per share; exercisable 6 months post-closing through January 24, 2016.
- Placement Agent Fees: 6% of gross proceeds plus warrants equal to 3% of shares sold (exercise price 125% of public offering price).
- Expense Reimbursement: 0.75% of gross proceeds, capped at $30,000.
Material Changes
The filing reports a significant capital raise event. The company entered into a Securities Purchase Agreement with certain investors to sell equity and warrants. This transaction represents a material change in the company's capital structure and cash position, with the offering expected to close on or about January 24, 2011.
Outlook, Risks, and Management Commentary
The company intends to use the net proceeds for general corporate purposes, though specific allocation is not detailed in this summary. The transaction is subject to the terms of the Securities Purchase Agreement and Placement Agent Agreement. Risks include the dilution of existing shareholders due to the issuance of new shares and warrants, and the potential future exercise of warrants which could further dilute equity. The filing notes that representations and warranties are made solely for the benefit of the contracting parties.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected January 24, 2011) and confirm receipt of net proceeds.
- Review the full text of the Securities Purchase Agreement (Exhibit 1.1) for specific covenants or restrictions.
- Monitor the company's use of the $2.6 million in net proceeds.
- Track the exercise of the 2,134,500 investor warrants and 128,070 placement agent warrants (3% of 4,269,000 shares) to assess future dilution.
- Confirm the company's current cash position and liquidity status post-closing.